FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA supplemental application for Zoledronic Acid submitted by Sagent Pharmaceuticals to modify the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis
• Prostate Cancer with Bone Metastases

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

SUPPL AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)